In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of ReShape Lifesciences Inc. (NASDAQ: RSLS) closed at $0.11 in the last session, down -10.11% from day before closing price of $0.12. In other words, the price has decreased by -$10.11 from its previous closing price. On the day, 2.44 million shares were traded. RSLS stock price reached its highest trading level at $0.1282 during the session, while it also had its lowest trading level at $0.11.
Ratios:
We take a closer look at RSLS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 31 ’24 when STANKOVICH THOMAS sold 48 shares for $0.25 per share. The transaction valued at 12 led to the insider holds 22,777 shares of the business.
STANKOVICH THOMAS sold 42 shares of RSLS for $10 on Dec 31 ’23. The Chief Financial Officer now owns 22,868 shares after completing the transaction at $0.25 per share. On Nov 30 ’23, another insider, STANKOVICH THOMAS, who serves as the Chief Financial Officer of the company, sold 39 shares for $0.23 each. As a result, the insider received 9 and left with 22,910 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RSLS now has a Market Capitalization of 56747 and an Enterprise Value of 190061712. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.41 while its Price-to-Book (P/B) ratio in mrq is 1.08. Its current Enterprise Value per Revenue stands at 23.622 whereas that against EBITDA is -20.675.
Stock Price History:
Over the past 52 weeks, RSLS has reached a high of $0.68, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -37.93%, while the 200-Day Moving Average is calculated to be -43.29%.
Shares Statistics:
According to the various share statistics, RSLS traded on average about 1.33M shares per day over the past 3-months and 19393 shares per day over the past 10 days. A total of 29.39M shares are outstanding, with a floating share count of 26.88M. Insiders hold about 8.54% of the company’s shares, while institutions hold 3.45% stake in the company. Shares short for RSLS as of 1724976000 were 10089 with a Short Ratio of 0.44, compared to 1722384000 on 11723. Therefore, it implies a Short% of Shares Outstanding of 10089 and a Short% of Float of 2.18.
